SCHEMBL19998971

SCHEMBL19998971

C=Cc1ccc(OCCCCCCOc2cc(C)c(OCCCCCCOc3ccc(C=C)cc3)cc2C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 2/20 0.50
CHRNB2 P17787 1/20 0.50
CHRNB4 P30926 1/20 0.50
CHRNA3 P32297 1/20 0.50
CHRNA4 P43681 1/20 0.50
MAPT P10636 2/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
MAOA P21397 2/20 0.40
MAOB P27338 2/20 0.40
TDP1 Q9NUW8 1/20 0.39
APP P05067 9/20 0.39
AHR P35869 1/20 0.39
ALB P02768 1/20 0.38
CHRNA10 Q9GZZ6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8754087 0.84 CHRNB2 (0.59) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL1140632 0.84 CHRNB2 (0.59) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL12114958 0.83 CHRNB2 (0.56) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL3565533 0.83 DRD2 (0.55) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL1260922 0.82 CHRNA7 (0.61) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL31329592 0.81 CHRNA7 (0.48) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL20005466 0.80 CHRNA7 (0.50) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL19971155 0.80 CHRNB2 (0.60) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL19971166 0.80 CHRNB2 (0.60) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL4906796 0.80 CHRNB2 (0.60) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180090687-A1 CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD (JP) 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180090687-A1 CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT SLC18A1, SLC1A2, SLC43A1 CHRNA7 192/4885CHRNB2 478/4885CHRNB4 450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.